What transformative clinical capabilities do premier oncology institutes deploy when pioneering breakthrough therapies like CAR-T cell immunotherapy and proton beam radiation, and why is integrating multidisciplinary precision oncology essential to maximizing overall patient survival rates in complex metastatic cases?